KEY POINTS • Preoperative risk stratification should be a comprehensive assessment with careful evaluation of active cardiac conditions, clinical risk factors, and planned surgical intervention. • Noninvasive ischemic evaluation should…
KEY POINTS • The assessment of patients with new-onset stable chest pain includes a detailed history assessment and ECG. • The current risk scores tend to overestimate the risk for…
KEY POINTS • A key physiologic attribute that defines the quality of a MPI agent is defined by the relationship between the tracer uptake and MBF. A linear relationship maximizes…
KEY POINTS • Accurate quantitative MBF quantification requires an understanding of the technical capabilities of the instrumentation and quantitative software used to make the measurements. • Quality control of MBF…
KEY POINTS • Before ordering any test, especially one associated with ionizing radiation, we must ensure the appropriateness of the study and that the potential benefits outweigh the risks. •…
KEY POINTS • The radionuclides of interest for PET emit positrons, the antiparticles of electrons. • Positrons interact with free electrons to produce two back-to-back 511-keV annihilation photons; PET imaging…
KEY POINTS • Conventional gamma cameras use one to three detectors, based on a NaI scintillation crystal and a photomultiplier tube array, that rotate around the patient. • Cameras commonly…
The use of PET imaging agents in oncology, cardiovascular disease, and neurodegenerative disease shows the power of this technique in evaluating the molecular and biological characteristics of numerous diseases. These…
Head and neck cancers are commonly encountered cancers in clinical practice in the United States. Fluorine-18-fluorodeoxyglucose ( 18 F-FDG) PET/CT has been clinically applied in staging, occult primary tumor detection,…
This review article summarizes the clinical applications of established and emerging PET tracers in the evaluation of the 5 most common gynecologic malignancies: endometrial, ovarian, cervical, vaginal, and vulvar cancers….
